U.S. Announces Final Negotiated Medicare Drug Prices For 10 Medicines
Aug 15 (Reuters) -U.S. Centers for Medicare & Medicaid Services:
U.S. ANNOUNCES FINAL NEGOTIATED MEDICARE DRUG PRICES FOR 10 MEDICINES
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR MERCK'S JANUVIA IS $113.00
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR BRISTOL MYERS' ELIQUIS AT $231
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR JANSSEN'S STELARA IS $4,695
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR PHARMACYCLICS' IMBRUVICA IS $9,319
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR J&J'S XARELTO IS $197.00
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR NOVARTIS PHARMS CORP'S ENTRESTO IS $295.00
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR ENBREL IS $2,355.00
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR NOVO NORDISK'S FIASP; FIASP FLEXTOUCH; FIASP PENFILL; NOVOLOG IS $119.00
U.S. CMS: WHEN NEGOTIATED PRICES GO INTO EFFECT IN 2026, PEOPLE ENROLLED IN MEDICARE PRESCRIPTION DRUG COVERAGE WOULD SAVE ESTIMATED $1.5 BILLION
U.S. CMS: AGREED NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR ASTRAZENECA'S FARXIGA AT $178.50
U.S. CMS: AGREED TO NEGOTIATED PRICE FOR 30- DAY SUPPLY FOR CY 2026 FOR BOEHRINGER INGELHEIM'S JARDIANCE AT $197
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
